Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.091 | 0.05 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.063 | 0.1 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |